Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
19.20
+0.09 (0.47%)
At close: Nov 17, 2026, 4:00 PM EST
19.18
-0.02 (-0.10%)
After-hours: Nov 17, 2026, 7:30 PM EST

Nuvectis Pharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
10.889.426.937.526.013.35
Research & Development
41.2518.1512.9214.3812.032.45
Operating Expenses
52.1227.5719.8521.918.035.79
Operating Income
-52.12-27.57-19.85-21.9-18.03-5.79
Interest & Investment Income
1.671.130.850.640.150
EBT Excluding Unusual Items
-50.45-26.44-19-21.26-17.89-5.79
Other Unusual Items
----1-1.2-7.1
Pretax Income
-50.45-26.44-19-22.26-19.09-12.89
Net Income
-50.45-26.44-19-22.26-19.09-12.89
Preferred Dividends & Other Adjustments
-2.43----
Net Income to Common
-50.45-28.87-19-22.26-19.09-12.89
Net Income Growth
------
Shares Outstanding (Basic)
25221716134
Shares Outstanding (Diluted)
25221716134
Shares Change
21.77%27.46%10.01%22.90%196.55%9.44%
EPS (Basic)
-2.03-1.32-1.11-1.43-1.51-3.02
EPS (Diluted)
-2.03-1.32-1.11-1.43-1.51-3.02
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EBIT
-52.12-27.57-19.85-21.9-18.03-5.79
SEC Filings: 10-K · 10-Q